LUMO - Lumos Pharma Inc. (LUMO) CEO Rick Hawkins on Q2 2021 Results - Earnings Call Transcript
Lumos Pharma, Inc. (LUMO) Q2 2021 Earnings Conference Call August 05, 2021, 11:00 AM ET Company Participants Lisa Miller - Senior Director-IR Rick Hawkins - CEO and Chairman John McKew - President and Chief Scientific Officer David Karpf - Chief Medical Officer Lori Lawley - CFO and Corporate Controller Conference Call Participants Charles Duncan - Cantor Fitzgerald Ed White - H.C. Wainwright Catherine Novack - Jones Trading Presentation Operator Good afternoon, ladies and gentlemen, and welcome to Lumos Pharma's Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Senior Director of Investor Relations. Ma' am please go ahead. Lisa Miller Thank you. Before we proceed with the call, I would like to remind
For further details see:
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q2 2021 Results - Earnings Call Transcript